This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiang, X. Articles by Yeung, R. S. Search for Related Content PubMed PubMed Citation Articles by Jiang, X. Articles by Yeung, R. S.

Regulation of Microtubule-Dependent Protein Transport by the TSC2/Mammalian Target of Rapamycin Pathway

Department of Surgery, University of Washington, Seattle, Washington

Requests for reprints: Raymond S. Yeung, Department of Surgery, University of Washington, Box 356410, 1959 Northeast Pacific, Seattle, WA 98195. Phone: 206-616-6405; Fax: 206-616-6406; E-mail: ryeung{at}u.washington.edu.

Protein transport plays a critical role in the interaction of the cell with its environment. Recent studies have identified TSC1 and TSC2, two tumor suppressor genes involved in tuberous sclerosis complex, as regulators of the mammalian target of rapamycin (mTOR) pathway. Cells deficient in TSC1 or TSC2 possess high levels of Rheb-GTP resulting in constitutive mTOR activation. We have shown previously that the TSC1/TSC2 complex is involved in post-Golgi transport of VSVG and caveolin-1 in mammalian cells. Here, we show that modulation of mTOR activity affects caveolin-1 localization and that this effect is independent of p70S6K. Tsc1- and Tsc2-null cells exhibit abnormal caveolin-1 localization that is accompanied by disorganized microtubules in the subcortical region. Analyses of green fluorescent protein-EB1 and tubulin in live mutant cells suggest a failure of the plus-ends to sense cortical signals and to halt microtubule growth. Down-regulation of CLIP-170, a putative mTOR substrate with microtubule-binding properties, rescued the abnormal microtubule arrangement and caveolin-1 localization in Tsc2–/– cells. Together, these findings highlight a novel role of the TSC2/mTOR pathway in regulating microtubule-dependent protein transport. (Cancer Res 2006; 66(10): 5258-69)

This article has been cited by other articles:

				L. M. DiBella, A. Park, and Z. Sun Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway Hum. Mol. Genet., February 15, 2009; 18(4): 595 - 606. [Abstract] [Full Text] [PDF]

				X. Jiang, H. Kenerson, L. Aicher, R. Miyaoka, J. Eary, J. Bissler, and R. S. Yeung The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake Am. J. Pathol., June 1, 2008; 172(6): 1748 - 1756. [Abstract] [Full Text] [PDF]

				R. T. Abraham and J. J. Gibbons The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy Clin. Cancer Res., June 1, 2007; 13(11): 3109 - 3114. [Abstract] [Full Text] [PDF]

				P. J. de Vries, P. A. Prather, D. Lipsker, P. A. Konstantinopoulos, A. G. Papavassiliou, P. B. Crino, K. L. Nathanson, and E. P. Henske The tuberous sclerosis complex. N. Engl. J. Med., January 4, 2007; 356(1): 92 - 93. [Full Text] [PDF]